Osaühing FibroTx

In liquidation Registry code 11183541 OÜ Tallinn Registered 7 Nov 2005
Compare

Osaühing FibroTx is a OÜ based in Tallinn, registry code 11183541, status: in liquidation. Main activity: Research and experimental development on biotechnology. According to EMTA, turnover for Q3 2026 was €0 with employees.

Turnover
0 €
State taxes
—
Labour taxes
—
Employees
—

Q3 2026 · data from the Tax and Customs Board (EMTA)

Position in the industry Scientific research and development · EMTAK 72

  • Revenue · 2023 52 978 €
    industry median 76 € · companies in the industry: 1 030
  • Net profit margin · 2023 -9 449.6 %
    industry median 16.8 % · companies in the industry: 596

Taxes and turnover

Q4 2023 – Q3 2026
Turnover, € Q3 2026: 0 € · industry median 14 442 € · above 2% of the industry
05 00010 00015 00020 000Q4 2023 Company: 0 € Industry median: 15 375 €Q4·23Q1 2024 Company: 0 € Industry median: 14 938 €Q2 2024 Company: 0 € Industry median: 14 999 €Q2·24Q3 2024 Company: 0 € Industry median: 11 985 €Q4 2024 Company: 0 € Industry median: 16 752 €Q4·24Q1 2025 Company: 0 € Industry median: 15 203 €Q2 2025 Company: 0 € Industry median: 14 420 €Q2·25Q3 2025 Company: 0 € Industry median: 13 763 €Q4 2025 Company: 0 € Industry median: 13 976 €Q4·25Q1 2026 Company: 0 € Industry median: 14 268 €Q2 2026 Company: 0 € Industry median: 14 545 €Q2·26Q3 2026 Company: 0 € Industry median: 14 442 €Q3·2605 00010 00015 00020 000Q4 2024 Company: 0 € Industry median: 16 752 €Q1 2025 Company: 0 € Industry median: 15 203 €Q1·25Q2 2025 Company: 0 € Industry median: 14 420 €Q3 2025 Company: 0 € Industry median: 13 763 €Q3·25Q4 2025 Company: 0 € Industry median: 13 976 €Q1 2026 Company: 0 € Industry median: 14 268 €Q1·26Q2 2026 Company: 0 € Industry median: 14 545 €Q3 2026 Company: 0 € Industry median: 14 442 €Q3·26
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

State taxes, € Q4 2023: 0 €
0.00.00.00.00.00.0Q4 2023 Company: 0 €Q4·23Q1 2024 Company: —Q2 2024 Company: —Q2·24Q3 2024 Company: —Q4 2024 Company: —Q4·24Q1 2025 Company: —Q2 2025 Company: —Q2·25Q3 2025 Company: —Q4 2025 Company: —Q4·25Q1 2026 Company: —Q2 2026 Company: —Q2·26Q3 2026 Company: —Q3·26
Figures by quarter
Quarter Turnover, € State taxes, € Labour taxes, € Employees
Q3 2026 — — — —
Q2 2026 — — — —
Q1 2026 — — — —
Q4 2025 — — — —
Q3 2025 — — — —
Q2 2025 — — — —
Q1 2025 — — — —
Q4 2024 — — — —
Q3 2024 — — — —
Q2 2024 — — — —
Q1 2024 — — — —
Q4 2023 — — 32 —
Q3 2023 — — — —
Q2 2023 — — — —
Q1 2023 2 760 17 627 31 723 —
Q4 2022 27 718 — 51 619 9
Q3 2022 57 273 — 28 279 16
Q2 2022 26 752 — 35 851 17
Q1 2022 118 364 12 549 34 129 20

Financials by year

2015 – 2025
Revenue, € thousand 2023: 52 978 € · −76.1% vs 2021 · industry median 76 € · above 87% of the industry
0501001502002502015 Company: — Industry median: —20152016 Company: — Industry median: —20162017 Company: — Industry median: —20172018 Company: — Industry median: —20182019 Company: 237 871 € Industry median: 0 €20192020 Company: 164 291 € Industry median: 150 €20202021 Company: 221 916 € Industry median: 0 €20212023 Company: 52 978 € Industry median: 76 €20232024 Company: — Industry median: 0 €20242025 Company: — Industry median: 0 €20250501001502002502017 Company: — Industry median: —2018 Company: — Industry median: —20182019 Company: 237 871 € Industry median: 0 €2020 Company: 164 291 € Industry median: 150 €20202021 Company: 221 916 € Industry median: 0 €2023 Company: 52 978 € Industry median: 76 €20232024 Company: — Industry median: 0 €2025 Company: — Industry median: 0 €2025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit, € thousand 2025: -232 565 € · +70.9% vs 2024 · industry median 0 € · above 2% of the industry
-6 000-4 000-2 00002 0002015 Company: — Industry median: —20152016 Company: — Industry median: —20162017 Company: — Industry median: —20172018 Company: — Industry median: —20182019 Company: -1 419 011 € Industry median: 3 €20192020 Company: -1 131 487 € Industry median: 28 €20202021 Company: -1 573 505 € Industry median: 1 €20212023 Company: -5 006 232 € Industry median: 0 €20232024 Company: -798 854 € Industry median: 0 €20242025 Company: -232 565 € Industry median: 0 €2025-6 000-4 000-2 00002 0002017 Company: — Industry median: —2018 Company: — Industry median: —20182019 Company: -1 419 011 € Industry median: 3 €2020 Company: -1 131 487 € Industry median: 28 €20202021 Company: -1 573 505 € Industry median: 1 €2023 Company: -5 006 232 € Industry median: 0 €20232024 Company: -798 854 € Industry median: 0 €2025 Company: -232 565 € Industry median: 0 €2025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit margin, % 2023: -9 449.6 % · −8 740.6 pp vs the year before · industry median 16.8 % · above 2% of the industry
-10 000-8 000-6 000-4 000-2 00002 0002015 Company: — Industry median: —20152016 Company: — Industry median: —20162017 Company: — Industry median: —20172018 Company: — Industry median: —20182019 Company: -596.5 % Industry median: 12.7 %20192020 Company: -688.7 % Industry median: 23.8 %20202021 Company: -709.1 % Industry median: 25.1 %20212023 Company: -9 449.6 % Industry median: 16.8 %20232024 Company: — Industry median: 15.8 %20242025 Company: — Industry median: 13.5 %2025-10 000-8 000-6 000-4 000-2 00002 0002017 Company: — Industry median: —2018 Company: — Industry median: —20182019 Company: -596.5 % Industry median: 12.7 %2020 Company: -688.7 % Industry median: 23.8 %20202021 Company: -709.1 % Industry median: 25.1 %2023 Company: -9 449.6 % Industry median: 16.8 %20232024 Company: — Industry median: 15.8 %2025 Company: — Industry median: 13.5 %2025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € thousand 2025: 2 € · −71.4% vs 2024
05001 0001 5002 0002 5002015 Company: —20152016 Company: —20162017 Company: —20172018 Company: —20182019 Company: 1 474 300 €20192020 Company: 1 562 594 €20202021 Company: 2 233 659 €20212023 Company: 607 €20232024 Company: 7 €20242025 Company: 2 €202505001 0001 5002 0002 5002017 Company: —2018 Company: —20182019 Company: 1 474 300 €2020 Company: 1 562 594 €20202021 Company: 2 233 659 €2023 Company: 607 €20232024 Company: 7 €2025 Company: 2 €2025
Equity, € thousand 2025: -11 345 162 € · −2.1% vs 2024
-12 500-10 000-7 500-5 000-2 50002015 Company: —20152016 Company: —20162017 Company: —20172018 Company: —20182019 Company: -2 602 519 €20192020 Company: -3 734 006 €20202021 Company: -5 307 511 €20212023 Company: -10 313 743 €20232024 Company: -11 112 597 €20242025 Company: -11 345 162 €2025-12 500-10 000-7 500-5 000-2 50002017 Company: —2018 Company: —20182019 Company: -2 602 519 €2020 Company: -3 734 006 €20202021 Company: -5 307 511 €2023 Company: -10 313 743 €20232024 Company: -11 112 597 €2025 Company: -11 345 162 €2025
Employees 2025: 0 · industry median 1 · above 2% of the industry
0510152015 Company: 6 Industry median: —20152016 Company: 7 Industry median: —20162017 Company: 13 Industry median: —20172018 Company: 13 Industry median: 120182019 Company: 14 Industry median: 120192020 Company: 9 Industry median: 120202021 Company: 9 Industry median: 120212023 Company: 7 Industry median: 120232024 Company: 0 Industry median: 120242025 Company: 0 Industry median: 120250510152017 Company: 13 Industry median: —2018 Company: 13 Industry median: 120182019 Company: 14 Industry median: 12020 Company: 9 Industry median: 120202021 Company: 9 Industry median: 12023 Company: 7 Industry median: 120232024 Company: 0 Industry median: 12025 Company: 0 Industry median: 12025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year Revenue, € Net profit, € Labour costs, € Assets, € Equity, € Employees
2025 — -232 565 — 2 -11 345 162 0
2024 — -798 854 — 7 -11 112 597 0
2023 52 978 -5 006 232 379 211 607 -10 313 743 7
2021 221 916 -1 573 505 449 134 2 233 659 -5 307 511 9
2020 164 291 -1 131 487 356 419 1 562 594 -3 734 006 9
2019 237 871 -1 419 011 421 476 1 474 300 -2 602 519 14
2018 — — — — — 13
2017 — — — — — 13
2016 — — — — — 7
2015 — — — — — 6
2014 — — — — — 8
2013 — — — — — 13
2012 — — — — — 12
2011 — — — — — 12
2010 — — — — — 12
2009 — — — — — 13
2008 — — — — — 13
2007 — — — — — 9
2006 — — — — — 7

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Financial ratios for 2025

Return on assets (ROA)
-11 628 250.0 %
Net profit / assets
Equity ratio
-567 258 100.0 %
Equity / assets
Debt ratio
567 258 200.0 %
Liabilities / assets
Current ratio
0.00
Current assets / current liabilities

Annual reports

PDFs from e-Äriregister
Annual reports
Year Period Filed Report Documents
2024 25 Apr 2024 – 24 Apr 2025 15 Oct 2025 Company’s own e-Äriregister
2023 25 Apr 2023 – 24 Apr 2024 13 Aug 2024 Company’s own e-Äriregister
2022 1 Jan 2022 – 24 Apr 2023 27 Jun 2023 Company’s own e-Äriregister
2021 1 Jan 2021 – 31 Dec 2021 7 Jul 2022 Company’s own e-Äriregister
2020 1 Jan 2020 – 31 Dec 2020 30 Jun 2021 Company’s own e-Äriregister
2019 1 Jan 2019 – 31 Dec 2019 14 Sep 2020 Company’s own e-Äriregister

Board

  • Aivar Linnamäe
    Liquidator · since 15 May 2023
  • Nasdaq CSD SE
    Keeper of the share register · since 28 Sep 2017

Owners

Beneficial owners

Founders and other persons

shared board members, owners or beneficial owners

Activities (EMTAK)

  • 72111Research and experimental development on biotechnology Main

History of changes

What Value Period
Status In liquidation 15 May 2023 – now
Status Active 7 Nov 2005 – now

Rulings 20

All rulings (PDF)
Rulings
Number, date Title Deadline State Document
Ä 10093182 / 17
15 May 2023
 Termination entry In force
15 May 2023
 PDF
Ä 10093182 / M3
3 May 2023
 Ruling to eliminate deficiencies 23 May 2023 Deficiencies eliminated
15 May 2023
 PDF
Ä 10093182 / 16
27 Dec 2019
 Amendment entry In force
27 Dec 2019
 PDF
Ä 10093182 / 15
5 Apr 2019
 Amendment entry In force
5 Apr 2019
 PDF
Ä 10093182 / 14
17 Jan 2018
 Amendment entry In force
17 Jan 2018
 PDF
Ä 10093182 / 13
29 Nov 2017
 Amendment entry In force
29 Nov 2017
 PDF
Ä 10093182 / 12
28 Sep 2017
 Amendment entry In force
28 Sep 2017
 PDF
Ä 10093182 / 11
11 Jun 2015
 Amendment entry In force
11 Jun 2015
 PDF
Ä 10093182 / 10
15 Apr 2013
 Amendment entry In force
15 Apr 2013
 PDF
Ä 10093182 / 9
26 Feb 2013
 Amendment entry In force
26 Feb 2013
 PDF
Ä 10093182 / 8
7 Nov 2012
 Entry refused: deficiencies not eliminated In force
30 Nov 2012
 PDF
Ä 10093182 / M2
3 Oct 2012
 Ruling to eliminate deficiencies 5 Nov 2012 In force
3 Oct 2012
 PDF
Ä 10093182 / 7
9 Mar 2012
 Amendment entry In force
9 Mar 2012
 PDF
Ä 10093182 / 6
30 Dec 2011
 Amendment entry In force
30 Dec 2011
 PDF
Ä 10093182 / M1
9 Dec 2011
 Ruling to eliminate deficiencies 31 Jan 2012 In force
9 Dec 2011
 PDF
Ä 10093182 / 5
21 Sep 2011
 Amendment entry In force
21 Sep 2011
 PDF
Ä 93182 / 4
5 Jan 2009
 Deletion of activities from the registry card In force
8 Jan 2009
 PDF
Ä 93182 / 3
26 May 2008
 Amendment entry In force
26 May 2008
 PDF
Ä 93182 / 2
4 May 2006
 Amendment entry In force
4 May 2006
 PDF
Ä 93182
7 Nov 2005
 First entry In force PDF

Sources: e-Äriregister and EMTA. Data updated 1 Nov 2026. Open at the source ↗ · Report an error in the data